Skip to main content
SOLARA ACTIVE PHARMA SCIENCES LIMITED logo

SOLARA ACTIVE PHARMA SCIENCES LIMITED — Investor Relations & Filings

Ticker · SOLARA ISIN · INE624Z01016 LEI · 3358008SUKH3YE2F7F81 BSE.NS Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country IN India
Listing BSE.NS SOLARA

About SOLARA ACTIVE PHARMA SCIENCES LIMITED

https://www.solara.co.in/

Solara Active Pharma Sciences Limited is a customer-centric organization specializing in the development and manufacturing of active pharmaceutical ingredients (APIs). The company offers a diverse portfolio of high-quality products across therapeutic categories such as pain management, central nervous system, and anti-infectives. It operates several manufacturing sites and research centers that comply with global regulatory standards, including the USFDA and EUGMP. Beyond its commercial API catalog, the company provides comprehensive contract development and manufacturing organization (CDMO) services, assisting partners from the initial research phase to large-scale production. Known for its significant production capacity in key molecules like Ibuprofen, the company focuses on delivering complex and niche APIs to global markets through advanced technical expertise and a commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Revised Intimation of Schedule of Investors/Analysts call to be held on Friday, May 15, 2026, 15.00 IST to discuss the Company''s audited financial results for the quarter and year ended ....
Regulatory Filings Classification · 13% confidence The document is a stock exchange intimation under SEBI Listing Regulations notifying a change in a panel member for an upcoming analysts/investors conference call. It does not contain financial results or presentation materials itself, nor is it the transcript; it is a regulatory compliance announcement. There is no detailed financial data or report attached. It falls under general regulatory filings as a compliance notice (fallback category).
2026-05-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a letter to the BSE and NSE notifying a change in panel members for an upcoming analysts/investors conference call under SEBI Listing Obligations. It does not contain financial statements or a transcript, nor is it a presentation itself; rather it is a regulatory announcement of an investor event. There is no specific category for a conference-call notice, so it falls into the general regulatory announcements/fallback category ‘Regulatory Filings’ (RNS).
2026-05-12 English
Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday, May 15, 2026 at 15.00 IST, to discuss the Company''s ....
Regulatory Filings Classification · 92% confidence The document is a notice to stock exchanges and investors about a scheduled conference call to discuss audited financial results. It does not include any financial statements, earnings highlights, or slides, nor is it a transcript of the call. It is not an earnings release, annual report, or investor presentation itself but rather a regulatory announcement of the call schedule. There is no specific meeting-notice category beyond the generic regulatory filings bucket, so it defaults to Regulatory Filings (RNS).
2026-05-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an official intimation to stock exchanges (BSE/NSE) announcing the scheduling of an analysts/investors conference call to discuss audited financial results. It does not contain the financial results themselves, nor a transcript, nor is it a presentation or detailed report; rather it is a regulatory announcement of an upcoming event. No specific category for “conference call notice” exists beyond the general regulatory announcements fallback. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-11 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-28 English
Press Release
Regulatory Filings
2026-04-28 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.